Cite

HARVARD Citation

    Komaki, H. et al. (2020). Early phase 2 trial of TAS‐205 in patients with Duchenne muscular dystrophy. Annals of clinical and translational neurology. 7 (2), pp. 181-190. [Online]. 
  
Back to record